The 340B Drug Pricing Program has been a lifeline for small rural hospitals and clinics, providing essential savings on outpatient drugs for providers serving low-income or uninsured patients, but it needs responsible reform to reduce “mission creep” and ensure continuation of its original intent as a safety net program.
